Probiotics in very preterm infants: the PiPS trial

The Lancet

Volumn 388, Issue 10045, 2016, Pages 655-

  Deshpande, Girish ^a   Rao, Shripada ^b   Athalye Jape, Gayatri ^b   Conway, Patricia ^c   Patole, Sanjay ^b  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; METHOTREXATE;

BACTERIAL COLONIZATION; BIFIDOBACTERIUM BREVE; CLINICAL TRIAL; HUMAN; LETTER; LOW DRUG DOSE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; INFANT; SEPSIS;

HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; METHOTREXATE; PROBIOTICS; SEPSIS;

EID: 84989211605     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31271-5     Document Type: Letter

References (5)

1. 1 Costeloe, K, Hardy, P, Juszczak, E, Wilks, M, Millar, MR, Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial. Lancet 387 (2016), 649–660.
2. 2 Costeloe KL, Jesudass R, Al Nakib L, et al. The early administration of Bifidobacterium breve strain BBG to very low birthweight infants: a pilot study. Pediatric Academic Societies Meeting; San Francisco, CA; May 1–4, 2004. 2802.
3. 3 Kitajima, H, Sumida, Y, Tanaka, R, Yuki, N, Takayama, H, Fujimura, M, Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 76 (1997), F101–F107.
4. 4 Ganguli, K, Walker, A, Probiotics in the prevention of necrotizing enterocolitis. J Clin Gastroenterol 45 (2011), S133–S138.
5. 5 Totsu, S, Yamasaki, C, Terahara, M, Uchiyama, A, Kusuda, S, Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int 56 (2014), 714–719.